Cargando…
Humoral Immunity to Allogeneic Immunoproteasome-Expressing Mesenchymal Stromal Cells Requires Efferocytosis by Endogenous Phagocytes
The extensive use of mesenchymal stromal cells (MSCs) over the last decade has revolutionized modern medicine. From the delivery of pharmacological proteins to regenerative medicine and immune modulation, these cells have proven to be highly pleiotropic and responsive to their surrounding environmen...
Autores principales: | Bikorimana, Jean-Pierre, Abusarah, Jamilah, Salame, Natasha, El-Hachem, Nehme, Shammaa, Riam, Rafei, Moutih |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869887/ https://www.ncbi.nlm.nih.gov/pubmed/35203247 http://dx.doi.org/10.3390/cells11040596 |
Ejemplares similares
-
The CIt protocol: A blueprint to potentiate the immunogenicity of immunoproteasome-reprogrammed mesenchymal stromal cells
por: Bikorimana, Jean-Pierre, et al.
Publicado: (2022) -
Thymoproteasome-Expressing Mesenchymal Stromal Cells Confer Protective Anti-Tumor Immunity via Cross-Priming of Endogenous Dendritic Cells
por: Bikorimana, Jean-Pierre, et al.
Publicado: (2021) -
Engineering immunoproteasome-expressing mesenchymal stromal cells: A potent cellular vaccine for lymphoma and melanoma in mice
por: Abusarah, Jamilah, et al.
Publicado: (2021) -
CD146 Defines a Mesenchymal Stromal Cell Subpopulation with Enhanced Suppressive Properties
por: Bikorimana, Jean-Pierre, et al.
Publicado: (2022) -
UM171A-induced ROS promote antigen cross-presentation of immunogenic peptides by bone marrow-derived mesenchymal stromal cells
por: Salame, Natasha, et al.
Publicado: (2022)